SAN FRANCISCO and GENEVA, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics Dr. Thomas Arendt from the University of Leipzig thapresented at the 3rd Alzheimer's focused Coalition for Concussion Treatment Summit. Under the terms of the agreement, AMBS and the University of Leipzig will have 12 months to negotiate a definitive license agreement, and the Company will work with Dr. Arendt to establish a Sponsored Research Agreement to outline the advancement of the therapeutic strategies into human clinical development. 12 months are coming up soon!!!
This gnat is loving it. Shedding shares profitably and still a substantial position (for me that is, our Supreme Leader likely holds millions of shares).
Whyever would people vote for a party that is pitted against them?
Looks like we bounced off the bottom. Bought some shares at the low, wanted more but waited too long. I think this is one of the best biotech buys right now. I wish Galena would say something about the Zuplenz launch, so we would know if it's actually being sold yet. I know they had to rebrand and relabel the product, and discard any older product. Another example about being in the dark on things Galena can be telling the investment community. They have so many positive things going on it would be easy to tell people about them.
Almost 2 hours have past and moveavgtrader stills avoids answering my question.
Believe me when I say to you..good luck with that one\, as I am trying to form an argument while I type.
My father in-law practiced medicine for 50 years and didn't waste the money that he earned, yet prospered according to the widely belief. Shortly after officially retiring (although doctors
never really get to retire as many former patients, family and friends still count on them for advice etc.) he was diagnosed with a disease in which the average survival rate was 3-5 years. He survived 20 years but was too old by all standards for the best treatment - a bone marrow transplant which is not authorized or available medicine to a patient over the age of 65. However weekly blood-draws, x-rays, other tests plus monthly medical visits and/or a hospitization or two plus $500/pill(s)/day quickly adds up to the million$$$ which would put more than just a dent in 99%,,,but then you must be wannabe 1%'er who just posts here for fun...or to have your education furthere...
The health implications of tobacco use are well established. Smoking is the cause of around 90% of lung cancer deaths and is responsible for around 80% of deaths from chronic obstructive pulmonary disease (COPD). Each year, smoking kills more than 480,000 Americans...
Sentiment: Strong Sell
Ranger, maybe it's time to start keeping an eye on it again.... no need to buy just watch could simply be a one day pop. Having a good day today considering most bios are down
smart move. my buys are strictly in depressed stocks. also in oil ETFs which are also depressed.
my favorite stock at these prices is STXS which is starting to turn around
I think Linda will probably hold off until the World Vaccine Congress in April before unveiling that data. It seems like a bigger audience, and more publicity. I think with data like this, we need to try to release it at a big conference. I think ASCO is just too restrictive with their timing and data. As long as we have a booth, people will find Linda to talk about the data, and the data will be circulating already before ASCO.